These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7544488)

  • 1. CYFRA 21-1--clinical applications and analytical requirements.
    Ebert W; Bodenmüller H; Hölzel W
    Scand J Clin Lab Invest Suppl; 1995; 221():72-80. PubMed ID: 7544488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
    Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
    Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer.
    Niklinski J; Furman M; Chyczewska E; Chyczewski L; Rogowski F; Laudanski J
    Eur Respir J; 1995 Feb; 8(2):291-4. PubMed ID: 7538933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
    Ebert W; Muley T; Drings P
    Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.
    van der Gaast A; Schoenmakers CH; Kok TC; Blijenberg BG; Cornillie F; Splinter TA
    Br J Cancer; 1994 Mar; 69(3):525-8. PubMed ID: 7510117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
    Stieber P; Dienemann H; Hasholzner U; Müller C; Poley S; Hofmann K; Fateh-Moghadam A
    Eur J Clin Chem Clin Biochem; 1993 Oct; 31(10):689-94. PubMed ID: 7507359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of the tumor marker CYFRA 21-1 in patients with lung cancer after surgery or chemotherapy].
    Zissimopoulos A; Stellos K; Permenopoulou V; Petrakis G; Theodorakopoulos P; Baziotis N; Thalassinos N
    Hell J Nucl Med; 2007; 10(1):62-6. PubMed ID: 17450257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYFRA 21-1 as a tumour marker for bronchogenic carcinoma.
    Rapellino M; Niklinski J; Pecchio F; Furman M; Baldi S; Chyczewski L; Ruffini E; Chyczewska E
    Eur Respir J; 1995 Mar; 8(3):407-10. PubMed ID: 7540561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring.
    Hamzaoui A; Thomas P; Castelnau O; Roux N; Roux F; Kleisbauer JP
    Lung Cancer; 1997 Mar; 16(2-3):191-202. PubMed ID: 9152950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA, CYFRA21-1 and SCC in non-small cell lung cancer.
    Moro D; Villemain D; Vuillez JP; Delord CA; Brambilla C
    Lung Cancer; 1995 Oct; 13(2):169-76. PubMed ID: 8581396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis.
    Pavićević R; Bubanović G; Franjević A; Stancić-Rokotov D; Samarzija M
    Coll Antropol; 2008 Jun; 32(2):485-98. PubMed ID: 18756899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
    Niklinski J; Furman M; Burzykowski T; Chyczewski L; Laudanski J; Chyczewska E; Rapellino M
    Br J Cancer; 1996 Sep; 74(6):956-60. PubMed ID: 8826865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment.
    Sugama Y; Kitamura S; Kawai T; Ohkubo A; Hasegawa S; Kuriyama T; Kato H; Fukuoka M; Ohkawa J
    Jpn J Cancer Res; 1994 Nov; 85(11):1178-84. PubMed ID: 7530241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.
    Chantapet P; Riantawan P; Lebnak P; Getngern P
    J Med Assoc Thai; 2000 Apr; 83(4):383-91. PubMed ID: 10808698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin fragment 19 (CYFRA 21-1) as a tumor marker in non-small cell lung cancer.
    Huang MS; Jong SB; Lin MS; Chong IW; Tsai MS; Lin HC; Hwang JJ
    Kaohsiung J Med Sci; 1996 Feb; 12(2):62-8. PubMed ID: 8709175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1.
    Paone G; De Angelis G; Munno R; Pallotta G; Bigioni D; Saltini C; Bisetti A; Ameglio F
    Eur Respir J; 1995 Jul; 8(7):1136-40. PubMed ID: 7589398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer.
    Stieber P; Bodenmüller H; Banauch D; Hasholzner U; Dessauer A; Ofenloch-Hähnle B; Jaworek D; Fateh-Moghadam A
    Clin Biochem; 1993 Aug; 26(4):301-4. PubMed ID: 7694815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
    Maeda Y; Segawa Y; Takigawa N; Takata I; Fujimoto N
    Intern Med; 1996 Oct; 35(10):764-71. PubMed ID: 8933183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
    Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
    Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.